Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom's Share Price Doubles in June as Caliper Continues to Sag

NEW YORK (GenomeWeb News) – Sequenom’s stock was by far the biggest gainer — more than doubling its price — in June among the 36 companies that comprise the GenomeWeb Daily News Index.
 
In a tough month for the stock market, in general, Sequenom’s shares rose 107.5 percent. On the other end of the spectrum, shares of Caliper Life Sciences continued to decline, falling 27.6 percent for the month of June.
 
As reported by GWDN on Wednesday, Sequenom’s shares hit a 52-week high of $17.52 during Wednesday trade on the Nasdaq, before closing at $17.37.
 
The San Diego-based firm’s shares have risen sharply over the past month after it said that a blinded study showed that its molecular test for Down syndrome correctly identified 100 percent of all Down syndrome samples without any false-positive outcomes.
 
Five other firms in the Index managed to record double-digit gains for the month. They include Bruker (+10.4 percent), Genomic Health (+10.7 percent), Illumina (+11 percent), Rosetta Genomics (+14.2 percent), and Nanogen (+15.1 percent).
 
The month of June, however, meant a decline in the value of many of the stocks in the Index with 23 of the 36 companies recording a drop in their share price.
 
Caliper led decliners for the month. The firm didn’t report any news for that period until it said on Monday that it had been added to the Russell 3000 Index.
 
Shares of the Hopkinton, Mass.-based firm have fallen more than 50 percent since the beginning of the year.
 
In addition to Caliper, two other firms in the Index had a loss of more than 20 percent for June: Accelrys (-25.9 percent) and Clinical Data (-25.4 percent).
 
Overall, the GWDN Index declined 3.5 percent for the month of June. In comparison, the Dow Jones Industrial Average tumbled 10.2 percent, the Nasdaq sank 9.1 percent, and the Nasdaq Biotech Index lost 3 percent.
 
While GenomeWeb Daily News covers many more firms than are in the Index, those that have been included have a significant portion of their business focused on molecular biology and cellular research tools and are publicly traded in the US.
 
 

GenomeWeb Daily News Index
Company
Ticker
Current Price
(June 30, 2008)
Last
Price
(May 30, 2008)
% change
Accelrys
ACCL
4.83 6.52 -25.92
Accelr8
AXK
4.40 4.62 -4.76
Affymetrix
AFFX
10.29 12.06 -14.68
Agilent
A
35.54 37.39 -4.95
Applied Biosystems
ABI
33.48 34.76 -3.68
Beckman
BEC
67.53 69.39 -2.68
Becton Dickinson
BDX
81.30 84.45 -3.73
Bio-Rad
BIO
80.89 89.48 -9.60
Bruker
BRKR
12.85 11.64 10.40
Caliper
CALP
2.59 3.58 -27.65
Celera
CRA
11.36 12.88 -11.80
Cepheid
CPHD
28.12 26.32 6.84
Clinical Data
CLDA
14.27 19.12 -25.37
CombiMatrix
CBMX
9.99 9.54 4.72
Compugen
CGEN
2.15 2.03 5.91
DeCode Genetics
DCGN
0.94 1.16 -18.97
Genomic Health
GHDX
19.15 17.30 10.69
Gen-Probe
GPRO
47.51 56.94 -16.56
Helicos BioSciences
HLCS
4.68 4.69 -0.21
Illumina
ILMN
87.11 78.48 11.00
Invitrogen
IVGN
39.26 45.96 -14.58
Luminex
LMNX
20.55 22.24 -7.60
MDS
MDZ
16.20 18.71 -13.42
Millipore
MIL
67.86 72.65 -6.59
Nanogen
NGEN
0.38 0.33 15.15
Nanosphere
NSPH
7.86 9.60 -18.13
Orchid Cellmark
ORCH
2.60 2.83 -8.13
PerkinElmer
PKI
27.85 28.28 -1.52
Qiagen
QGEN
20.13 19.91 1.10
Rosetta Genomics
ROSG
4.75 4.16 14.18
Sequenom
SQNM
15.96 7.69 107.54
Sigma-Aldrich
SIAL
55.73 58.76 -5.16
Thermo
TMO
55.73 59.02 -5.57
Third Wave
TWTI
11.16 10.61 5.18
Vermillion
VRML
2.27 2.08 9.13
Waters
WAT
64.50 61.52 4.84
GWDN Index Average 26.99
27.96
-3.47
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.